Related Experiment Video
Updated: Jul 9, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Community-Acquired Pneumonia in Children
Chris A Rees, Nathan Kuppermann1, Todd A Florin2
1Professor, Departments of Emergency Medicine and Pediatrics, University of California Davis Health, University of California Davis, School of Medicine, Sacramento, CA.
Community-acquired pneumonia (CAP) in children is a major global health concern. Viral causes are now more common than bacterial ones, necessitating updated diagnostic and treatment strategies for pediatric CAP.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Community-acquired pneumonia (CAP) is a leading cause of mortality in children worldwide.
- In the U.S., CAP significantly contributes to pediatric hospitalizations, antibiotic use, and morbidity.
- Microbiological causes of pediatric CAP have shifted, with viral etiologies now predominating over pneumococcal pneumonia.
Purpose of the Study:
- To review the current understanding of pediatric CAP.
- To discuss the evolving microbiological landscape, clinical presentation, and diagnostic challenges.
- To outline evidence-based treatment and future research directions for pediatric CAP.
Main Methods:
- Literature review of recent studies on pediatric CAP.
- Analysis of trends in microbiological etiologies.
- Synthesis of current diagnostic and treatment guidelines.
Main Results:
- Viral pathogens are the primary cause of CAP in children.
- A standardized diagnostic approach for pediatric CAP is lacking.
- Narrow-spectrum antibiotics are recommended for indicated antimicrobial treatment.
Conclusions:
- The changing etiology of pediatric CAP requires a re-evaluation of diagnostic and management strategies.
- Further research is needed to establish optimal diagnostic criteria and therapeutic interventions.
- Addressing pediatric CAP effectively requires a multidisciplinary approach focusing on current epidemiological trends.
More Related Videos
12:18Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pneumonia II: Pathophysiology